Skip to content
healthcare.dev

Ethacrynic Acid

NDC 50228-334, Ethacrynic Acid, tablet, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-334
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211232
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETHACRYNIC ACID25 mg/1

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
50228-334-01502280334011000 TABLET in 1 BOTTLE (50228-334-01)
50228-334-1050228033410100 TABLET in 1 BOTTLE (50228-334-10)
50228-334-305022803343030 TABLET in 1 BOTTLE (50228-334-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d400d264-c231-4bdf-8180-eb11ab4e9f29
  • NADAC price for package 50228033410

    GET /v1/drugs/nadac/50228033410

Use it

Look up 50228-334 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.